Ardena has US-Präsenz and Unterzeichnet Vereinbarung zur Akquisition a high modern recuperation sanlage for Arzneimittel von Catalent

GHENT, Belgium, October 15, 2024 (GLOBE NEWSWIRE) — Ardena, a matter of care management and special recovery, Pharmaunternehmen (Contract Development and Manufacturing Organization, CDMO) with GMP Standards in Belgium, Spain, the Netherlands and Sweden, how the final analysis of a Catalent advanced drug manufacturing facility in Somerset, New Jersey, was conducted. The overarching importance is important for the competition in the history of the clinical phase and being small, making major analyzes and choosing an alternative strategy for a global CDMO, which provides integral solutions for the joint pharmaceutical managed company, ausbauen.

The FDA Zugelassene Standard in Somerset has followed 200 qualification experts and experts and is a center of competition for the high quality of oral Darreichungsformen, a best expertise of Ardena in the oral verabreichungsformen for fulfillment standards. With the acquisition, the position of the bioanalytical service in the United States is a fact and a company can be deployed by standard increasing additional and critical services for business services. The state-of-the-art recovery technology and analytical components of the standards have been developed by the integrated Vorgehensweise von Ardena, which links solutions for pharmaceutical and biotechnology in both Atlantic markets.

“Der heutige Tag marks one of the most important Meilenstein in the international Wachstumsstrategy of Ardena,” explains Jeremie Trochu, Chief Executive Officer of Ardena. „Wir friends our sehr, the talented scientific and operative team in Somerset in the Family von Ardena will come to the heißen. Das Engagement is a team for excellent service that is perfect with our Grundwerten: Exzellenz, Zuverlässigkeit, Sorgfalt und Integrität. Gemeinsam will continue to develop new biopharmaceuticals, die on the cutting edge of innovation, so that patients can benefit from improved therapies.”

“This expansion in North America is for the Ardena of the entscheidende beddeutung, where our global Präsenz weiter ausbauen wollen is”, so Trochu. “During the development of the technology with the heiß-schmelz extrusion, there is no longer a single solution for biotechnology, but our expertise in the innovative nanomedicine drug delivery system. If these investments are made, our investments and our investments will be expanded, one of our international skills is that we can operate our money business.”

GHO Capital, Ardena’s private equity partner, has made the war bigger and the realization of Ardena’s transatlantic expansion will continue to expand. The partner of GHO Capital makes the following comments: “Wir friends, that’s what this bedeutende Übernahme zommende kommen ist. As a result, the technological and market-relevant experts in the Schlüsselregionen have been strengthened and the future has been improved for future success and long-lasting success in the future of the future.”

The Abschluss of the Transaction during Anfang 2025 was one of the most important ways to carry out general transactions and other üblicher Abschlussbedingungen.

Hints for editors:

Uber Ardena

Ardena is a new, innovative and complex molecule for developing lung and lung repair agents for the new, innovative and complex molecules. Ardena believes it is important that the time and therapy of the next generation ends up in the problems and the patients.

Ardena has developed biopharmaceutical drugs at the Erforschung und Entwicklung of Arzneimitteln, an effective and regulatory compliant Wirkstoffe und Arzneiprodukte for clinical studies in the entwickeln. This is an Ardena-integrated Lösungen, which offers the Festkörperchemical, API- and Nanomedizinentwicklung und -Herstellung, Formulierungsentwicklung, und -Herstellung of Arzneimitteln bioanalytical and CMC-regulatory Services.

A photo of the latter can be found at http://www.globenewswire.com/NewsRoom/AttachmentNg/1be1c9c2-0305-4238-b377-4e11a264d6d8